{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:00:22Z","timestamp":1791201622757,"version":"4.2.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Egypt. Public. Health. Assoc."],"DOI":"10.1186\/s42506-026-00235-0","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:32:02Z","timestamp":1791199922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of lipid accumulation product on cardiometabolic multimorbidity and the mediating effect of leukocytes: evidence from a prospective cohort study among middle-aged and elderly chinese adults"],"prefix":"10.1186","volume":"101","author":[{"given":"Awakere","family":"Maiturouze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"6","key":"235_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/CM9.0000000000001985","volume":"135","author":"J Fan","year":"2022","unstructured":"Fan J, Sun Z, Yu C, Guo Y, Pei P, Yang L, et al. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults. Chin Med J (Engl). 2022;135(6):648\u201357. https:\/\/doi.org\/10.1097\/CM9.0000000000001985.","journal-title":"Chin Med J (Engl)"},{"key":"235_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2021.08.034","volume":"340","author":"W Wang","year":"2021","unstructured":"Wang W, Liu Y, Liu J, Yin P, Wang L, Qi J, et al. Mortality and years of life lost of cardiovascular diseases in China, 2005\u20132020: empirical evidence from national mortality surveillance system. Int J Cardiol. 2021;340:105\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2021.08.034.","journal-title":"Int J Cardiol"},{"issue":"1","key":"235_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"Emerging Risk Factors Collaboration","year":"2015","unstructured":"Emerging Risk Factors Collaboration. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52\u201360. https:\/\/doi.org\/10.1001\/jama.2015.7008.","journal-title":"JAMA"},{"issue":"10","key":"235_CR4","doi-asserted-by":"publisher","first-page":"e2238361","DOI":"10.1001\/jamanetworkopen.2022.38361","volume":"5","author":"JJ Joseph","year":"2022","unstructured":"Joseph JJ, Rajwani A, Roper D, Zhao S, Kline D, Odei J, et al. Associations of cardiometabolic multimorbidity with all-cause and coronary heart disease mortality among Black adults in the Jackson Heart Study. JAMA Netw Open. 2022;5(10):e2238361. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.38361.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"235_CR5","doi-asserted-by":"publisher","first-page":"glaf009","DOI":"10.1093\/gerona\/glaf009","volume":"80","author":"S Chen","year":"2025","unstructured":"Chen S, Qui\u00f1ones AR, Nagel CL, Bishop NJ, Allore HG, Newsom JT, et al. Cardiometabolic multimorbidity and dementia onset among middle-aged and older adults: differences by race\/ethnicity. J Gerontol Biol Sci Med Sci. 2025;80(5):glaf009. https:\/\/doi.org\/10.1093\/gerona\/glaf009.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"3","key":"235_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3945\/ajcn.112.047506","volume":"98","author":"F Abbasi","year":"2013","unstructured":"Abbasi F, Blasey C, Reaven GM. Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr. 2013;98(3):637\u201340. https:\/\/doi.org\/10.3945\/ajcn.112.047506.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"235_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S2213-8587(23)00344-3","volume":"12","author":"DJA Jenkins","year":"2024","unstructured":"Jenkins DJA, Willett WC, Yusuf S, Hu FB, Glenn AJ, Liu S, et al. Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants. Lancet Diabetes Endocrinol. 2024;12(2):107\u201318. https:\/\/doi.org\/10.1016\/S2213-8587(23)00344-3.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"235_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.numecd.2023.10.015","volume":"34","author":"S Chen","year":"2024","unstructured":"Chen S, Luo M, Sheng Z, Zhou R, Xiang W, Huang W, et al. Association of lipid accumulation product with all-cause and cardiovascular disease mortality: result from NHANES database. Nutr Metab Cardiovasc Dis. 2024;34(6):1467\u201376. https:\/\/doi.org\/10.1016\/j.numecd.2023.10.015.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"235_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2017.09.022","volume":"266","author":"A Marcadenti","year":"2017","unstructured":"Marcadenti A, Fuchs FD, Moreira LB, Gus M, Fuchs SC. Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference. Atherosclerosis. 2017;266:145\u201350. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.022.","journal-title":"Atherosclerosis"},{"key":"235_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS. The lipid accumulation product performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26. https:\/\/doi.org\/10.1186\/1471-2261-5-26.","journal-title":"BMC Cardiovasc Disord"},{"key":"235_CR11","doi-asserted-by":"publisher","first-page":"1201132","DOI":"10.3389\/fendo.2023.1201132","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Gui J, Liu H, Guo LL, Li J, Lei Y, et al. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1201132. https:\/\/doi.org\/10.3389\/fendo.2023.1201132.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"235_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13098-024-01516-4","volume":"16","author":"A Mansoori","year":"2024","unstructured":"Mansoori A, Allahyari M, Mirvahabi MS, Tanbakuchi D, Ghoflchi S, Derakhshan-Nezhad E, et al. Predictive properties of novel anthropometric and biochemical indexes for prediction of cardiovascular risk. Diabetol Metab Syndr. 2024;16(1):304. https:\/\/doi.org\/10.1186\/s13098-024-01516-4.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"235_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13690-025-01520-8","volume":"83","author":"Z Kang","year":"2025","unstructured":"Kang Z, Ye Y, Xiao H, Liu L. The relationship between frailty and major adverse cardiovascular and cerebrovascular events in Chinese older adults: the mediating effect of lipid accumulation products. Arch Public Health. 2025;83(1):33. https:\/\/doi.org\/10.1186\/s13690-025-01520-8.","journal-title":"Arch Public Health"},{"issue":"9","key":"235_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ejcn.2012.83","volume":"66","author":"C Xia","year":"2012","unstructured":"Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr. 2012;66(9):1035\u20138. https:\/\/doi.org\/10.1038\/ejcn.2012.83.","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"235_CR15","doi-asserted-by":"publisher","first-page":"107491","DOI":"10.1016\/j.jdiacomp.2019.107491","volume":"34","author":"M Mazidi","year":"2020","unstructured":"Mazidi M. Surrogate markers of insulin resistance and arterial stiffness. J Diabetes Complications. 2020;34(6):107491. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107491.","journal-title":"J Diabetes Complications"},{"issue":"15","key":"235_CR16","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"JA Kim","year":"2006","unstructured":"Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888\u2013904. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.563213.","journal-title":"Circulation"},{"issue":"1","key":"235_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.amjcard.2007.07.053","volume":"101","author":"NM Hamburg","year":"2008","unstructured":"Hamburg NM, Larson MG, Vita JA, Vasan RS, Keyes MJ, Widlansky ME, et al. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008;101(1):82\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2007.07.053.","journal-title":"Am J Cardiol"},{"issue":"1","key":"235_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2013.12.023","volume":"233","author":"N Alexopoulos","year":"2014","unstructured":"Alexopoulos N, Katritsis D, Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis. 2014;233(1):104\u201312. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.12.023.","journal-title":"Atherosclerosis"},{"issue":"5","key":"235_CR19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/oby.22167","volume":"26","author":"T Wang","year":"2018","unstructured":"Wang T, Zhang R, Ma X, Wang S, He Z, Huang Y, et al. Causal association of overall obesity and abdominal obesity with type 2 diabetes: a Mendelian randomization analysis. Obes (Silver Spring). 2018;26(5):934\u201342. https:\/\/doi.org\/10.1002\/oby.22167.","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"235_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1114248.","journal-title":"N Engl J Med"},{"issue":"1","key":"235_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-022-01670-x","volume":"21","author":"T Qiao","year":"2022","unstructured":"Qiao T, Luo T, Pei H, Yimingniyazi B, Aili D, Aimudula A, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):225. https:\/\/doi.org\/10.1186\/s12933-022-01670-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"235_CR22","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2468-2667(17)30074-9","volume":"2","author":"M Kivim\u00e4ki","year":"2017","unstructured":"Kivim\u00e4ki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277\u201385. https:\/\/doi.org\/10.1016\/S2468-2667(17)30074-9.","journal-title":"Lancet Public Health"},{"issue":"1","key":"235_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-025-02761-1","volume":"24","author":"L Zhou","year":"2025","unstructured":"Zhou L, Wang J, Zhou Z, Wang L, Guo Q, Zeng H, et al. Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study. Cardiovasc Diabetol. 2025;24(1):198. https:\/\/doi.org\/10.1186\/s12933-025-02761-1.","journal-title":"Cardiovasc Diabetol"},{"key":"235_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12986-019-0399-7","volume":"16","author":"G Yan","year":"2019","unstructured":"Yan G, Li F, Elia C, Zhao Y, Wang J, Chen Z, et al. Association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes in Chinese adults: a cohort study. Nutr Metab (Lond). 2019;16:72. https:\/\/doi.org\/10.1186\/s12986-019-0399-7.","journal-title":"Nutr Metab (Lond)"},{"key":"235_CR25","doi-asserted-by":"publisher","first-page":"977625","DOI":"10.3389\/fendo.2022.977625","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Zhang Y, Luo H, Lin R. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Front Endocrinol (Lausanne). 2022;13:977625. https:\/\/doi.org\/10.3389\/fendo.2022.977625.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"235_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","volume":"22","author":"M Ebrahimi","year":"2023","unstructured":"Ebrahimi M, Seyedi SA, Nabipoorashrafi SA, Rabizadeh S, Sarzaeim M, Yadegar A, et al. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Lipids Health Dis. 2023;22(1):41. https:\/\/doi.org\/10.1186\/s12944-023-01802-6.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"235_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12944-024-02190-1","volume":"23","author":"BS Witarto","year":"2024","unstructured":"Witarto BS, Witarto AP, Visuddho V, Wungu CDK, Maimunah U, Rejeki PS, et al. Gender-specific accuracy of lipid accumulation product index for the screening of metabolic syndrome in general adults: a meta-analysis and comparative analysis with other adiposity indicators. Lipids Health Dis. 2024;23(1):198. https:\/\/doi.org\/10.1186\/s12944-024-02190-1.","journal-title":"Lipids Health Dis"},{"issue":"14","key":"235_CR28","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.3390\/nu15143168","volume":"15","author":"Q Shao","year":"2023","unstructured":"Shao Q, Li J, Wu Y, Liu X, Wang N, Jiang Y, et al. Enhanced predictive value of lipid accumulation product for identifying metabolic syndrome in the general population of China. Nutrients. 2023;15(14):3168. https:\/\/doi.org\/10.3390\/nu15143168.","journal-title":"Nutrients"},{"key":"235_CR29","doi-asserted-by":"publisher","first-page":"691849","DOI":"10.3389\/fendo.2021.691849","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Sun H, Qiu S, Tao H, Yu J, Sun Z. Lipid accumulation product combined with urine glucose excretion improves the efficiency of diabetes screening in Chinese adults. Front Endocrinol (Lausanne). 2021;12:691849. https:\/\/doi.org\/10.3389\/fendo.2021.691849.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"235_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13098-023-01056-3","volume":"15","author":"CY Lin","year":"2023","unstructured":"Lin CY, Li JB, Wu F, Wang JJ, An HH, Qiu HN, et al. Comparison of lipid accumulation product and visceral adiposity index with traditional obesity indices in early-onset type 2 diabetes prediction: a cross-sectional study. Diabetol Metab Syndr. 2023;15(1):111. https:\/\/doi.org\/10.1186\/s13098-023-01056-3.","journal-title":"Diabetol Metab Syndr"},{"key":"235_CR31","doi-asserted-by":"publisher","first-page":"1224889","DOI":"10.3389\/fendo.2023.1224889","volume":"14","author":"M Tang","year":"2023","unstructured":"Tang M, Yao S, Cao H, Wei X, Zhen Q, Tan Y, et al. Interrelation between the lipid accumulation product index and diabetic kidney disease in patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2023;14:1224889. https:\/\/doi.org\/10.3389\/fendo.2023.1224889.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"235_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12944-024-02325-4","volume":"23","author":"B Wei","year":"2024","unstructured":"Wei B, Zhou L, Shu BL, Huang QY, Chai H, Yuan HY, et al. Association of diabetic retinopathy with plasma atherosclerotic index, visceral obesity index, and lipid accumulation products: NHANES 2005\u20132008. Lipids Health Dis. 2024;23(1):331. https:\/\/doi.org\/10.1186\/s12944-024-02325-4.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"235_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12986-024-00833-9","volume":"21","author":"Y Tan","year":"2024","unstructured":"Tan Y, Wu Y, Ding X, Liang X, Zhao W, Liu C, et al. A prospective cohort study on the effect of lipid accumulation product index on the incidence of cardiovascular diseases. Nutr Metab (Lond). 2024;21(1):55. https:\/\/doi.org\/10.1186\/s12986-024-00833-9.","journal-title":"Nutr Metab (Lond)"},{"key":"235_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2018.10.015","volume":"279","author":"I Kyrou","year":"2018","unstructured":"Kyrou I, Panagiotakos DB, Kouli GM, Georgousopoulou E, Chrysohoou C, Tsigos C, et al. Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: the ATTICA study. Atherosclerosis. 2018;279:10\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.10.015.","journal-title":"Atherosclerosis"},{"issue":"1","key":"235_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","volume":"23","author":"A Colantoni","year":"2024","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, et al. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):175. https:\/\/doi.org\/10.1186\/s12933-024-02263-6.","journal-title":"Cardiovasc Diabetol"},{"key":"235_CR36","doi-asserted-by":"publisher","first-page":"770200","DOI":"10.3389\/fendo.2021.770200","volume":"12","author":"J Yu","year":"2021","unstructured":"Yu J, Yi Q, Hou L, Chen G, Shen Y, Song Y, et al. Transition of lipid accumulation product status and the risk of type 2 diabetes mellitus in middle-aged and older Chinese: a national cohort study. Front Endocrinol (Lausanne). 2021;12:770200. https:\/\/doi.org\/10.3389\/fendo.2021.770200.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"235_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12986-024-00864-2","volume":"21","author":"X Chen","year":"2024","unstructured":"Chen X, Zhao Y, Sun J, Jiang Y, Tang Y. Identification of metabolic syndrome using lipid accumulation product and cardiometabolic index based on NHANES data from 2005 to 2018. Nutr Metab (Lond). 2024;21(1):96. https:\/\/doi.org\/10.1186\/s12986-024-00864-2.","journal-title":"Nutr Metab (Lond)"},{"key":"235_CR38","doi-asserted-by":"publisher","first-page":"2874122","DOI":"10.1155\/2024\/2874122","volume":"2024","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang X, Zeng L. Lipid accumulation product as a predictor of prediabetes and diabetes: insights from NHANES data (1999\u20132018). J Diabetes Res. 2024;2024:2874122. https:\/\/doi.org\/10.1155\/2024\/2874122.","journal-title":"J Diabetes Res"},{"key":"235_CR39","unstructured":"China Health and Retirement Longitudinal Study (CHARLS). Available from: https:\/\/charls.pku.edu.cn\/. Accessed 15 Sep 2026."}],"container-title":["Journal of the Egyptian Public Health Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42506-026-00235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42506-026-00235-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42506-026-00235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:32:03Z","timestamp":1791199923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42506-026-00235-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1186\/s42506-026-00235-0","relation":{},"ISSN":["2090-262X"],"issn-type":[{"value":"2090-262X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was a secondary analysis of publicly available, de-identified data from the China Health and Retirement Longitudinal Study (CHARLS); no additional ethics approval was obtained for this secondary analysis. The original CHARLS study was approved by the Biomedical Ethics Committee of Peking University (approval number: IRB00001052-11015), and all participants provided written informed consent.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30"}}